v3.26.1
SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details)
6 Months Ended
Jun. 30, 2026
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares granted 6,562,741
Number of shares forfeited
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares granted 12,152,741
Restricted Stock Units (RSUs) [Member] | Viral Clear Pharmaceuticals Inc [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares beginning balance 2,037,500
Weighted average grant date fair value beginning balance | $ / shares $ 5.36
Number of shares granted 12,152,741
Weighted average grant date fair value granted | $ / shares $ 2.39
Number of shares vested (7,902,471)
Weighted average grant date fair value vested | $ / shares $ 3.13
Number of shares forfeited (398,500)
Weighted average grant date fair value forfeited | $ / shares $ 3.40
Number of shares ending balance 5,889,270
Weighted average grant date fair value ending balance | $ / shares $ 2.37
Vested restricted shares
Weighted average grant date fair value vested restricted shares | $ / shares
Unvested restricted shares 5,889,270
Weighted average grant date fair value unvested restricted | $ / shares $ 2.37